Skip to main content

Role of Prostaglandins and Thromboxane

  • Conference paper
Septic Shock

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 4))

Abstract

The leading role of prostaglandins (PG’s) and thromboxane (TX) in septic shock is mainly based on five entities:

  1. 1.

    Molecular identity;

  2. 2.

    Known pharmacology;

  3. 3.

    Normally “not present” in circulating blood;

  4. 4.

    Potential correlation with clinical symptoms;

  5. 5.

    New therapeutical perspectives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Piper P, Vane J, Wyllie J (1970) Inactivation of prostaglandins by the lung. Nature 255: 600604

    Google Scholar 

  2. Hyman AL, Spannhake EW, Kadowitz PJ (1978) Prostaglandins and the lung, state of the art. Am Rev Respir Dis 117: 111–136

    PubMed  CAS  Google Scholar 

  3. Zawada ET (1984) The adaptive role of renal prostaglandin production: current clinical problems and future clinical horizons. Nephron 36: 77–90

    Article  PubMed  Google Scholar 

  4. Patrono C, Pugliese F, Ciabattoni G, Patrignani P, Maseri A, Chierchia S (1982) Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 69: 231234

    Google Scholar 

  5. Bunting S, Moncada S, Vane JR (1983) The prostacyclin-thromboxane balance: Pathophysiological and therapeutic implications. Br Med Bull 39: 271–283

    Google Scholar 

  6. Dahinden C, Galanos C, Fehr J (1983) Granulocyte activation by endotoxin. J Immun 130: 857–859

    PubMed  CAS  Google Scholar 

  7. Solomkin JS, Simmons RL (19837 Cellular and subcellular mediators of acute inflammation. Surg Clin North Am 62: 225–236

    Google Scholar 

  8. Rietschel ET, Schade U, Luderitz O, Fischer H, Peskar BA (1980) Prostaglandins in endotoxicosis. In: Schlessinger D (ed) Microbiology. Amer Soc Microbiology, Washington DC

    Google Scholar 

  9. Hess ML, Hastillo A, Greenfield LJ (1981) Spectrum of cardiovascular function during gram-negative sepsis. Prog Cardiovasc Dis 23: 279–301

    Article  PubMed  CAS  Google Scholar 

  10. Green K, Hedqvist P, Svanborg N (1974) Increased plasma levels of 15-keto-13, 14-dihydroprostaglandin F2 after allergen-provoked asthma in man. Lancet 1419–1421

    Google Scholar 

  11. Dawson W, Boot JR, Cockerill AF, Mallen DNB, Osborne DJ (1976) Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung. Nature 262: 699–703

    Article  PubMed  CAS  Google Scholar 

  12. Spannhake EW, Lehmann RJ, Wegmann MJ, Heyman AL, Kadowitz PJ (1978) Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J Appl Physiol 44: 397–403

    PubMed  CAS  Google Scholar 

  13. Anderson FL, Tsagaris TJ, Jubiz W, Kuida H (1975) Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol 228: 1479–1483

    CAS  Google Scholar 

  14. Nakano J (1972) Relationship between the chemical structure of prostaglandins and their vasoactivities in dogs. Br J Pharmacol 44: 63–68

    PubMed  CAS  Google Scholar 

  15. Newball HH, Keiser HR, Lenfant C (1980) Prostaglandin F2 functions as a local hormone on human airways. Respir Physiol 41: 183–190

    Article  PubMed  CAS  Google Scholar 

  16. Oettinger WKE, Walter GO, Jensen UM, Beyer A, Peskar BA (1983) Endogenous prostaglandin F2, in the hyerdynamic state of severe sepsis in man. Br J Surg 70: 237–239

    Article  PubMed  CAS  Google Scholar 

  17. Oettinger W, Berger D, Beger HG (1987) The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Klin Wochenschr 65: 61–68

    Article  PubMed  CAS  Google Scholar 

  18. Oettinger W (1983) Contributions of the prostaglandin system to the pathogenesis of clinical and experimental septic shock. In: Lewis DH, Haglund U (eds) Shock research. Elsevier, Amsterdam, pp 43–51

    Google Scholar 

  19. Frölich JL, Ogletree M, Peskar BA, Brigham KL (1980) Pulmonary hypertension correlated to pulmonary thromboxane synthesis. In: Samuellson B, Ramwell PW, Paoletti R (eds) Advances in prostaglandins and thromboxane research. Raven Press 7, New York, pp 745–750

    Google Scholar 

  20. Reines HD, Halushka PV, Cook JA, Wise WC, Rambo W (1982) Plasma thromboxane concentration are raised in patients dying with septic shock. Lancet 2: 174–175

    Article  PubMed  CAS  Google Scholar 

  21. Ball HA, Cook JA, Wise WC, Halushka PV (1986) Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med 12: 116–126

    Article  PubMed  CAS  Google Scholar 

  22. Ogletree ML, Brigham KL (1979) Indomethacin augments endotoxin induced increased lung vascular permeability in sheep. Am Rev Respir Dis 119: 383–389

    Google Scholar 

  23. Oettinger W, Beyer A, Jensen U, Zumtobel V (1981) Endogenous thromboxane and prostacyclin activity regarding cardiopulmonary disorders and early renal failure in septic surgical patients. Eur Surg Res 13 (1): 23

    Google Scholar 

  24. Halushka PV, Reines HD, Barrow SE, et al (1985) Elevated plasma 6-keto-prostaglandin Fla in patients in septic shock. Crit Care Med 13: 451–453

    Article  PubMed  CAS  Google Scholar 

  25. Nakano J, Prancan AV (1973) Metabolic degradation of prostaglandin E1 in the lung and kidney of rats in endotoxin shock. Proc Soc Exp Biol Med 144: 506–508

    PubMed  CAS  Google Scholar 

  26. Blackwell GJ, Flower RJ, Hermann AG (1976) Effect of endotoxin on 15-hydroxyprostaglandindehydrogenase in the rabbit jejunum and lung. Arch Int Pharmacodyn Ther 220: 325–328

    PubMed  CAS  Google Scholar 

  27. Oettinger W, Roscher R, Buscham K, Jonescu J, Beger HG (1985) Organ related prostaglandin (PG) release in porcine endotoxic shock. Eur Surg Res 17 (1): 88–89

    Google Scholar 

  28. Kawasaki A, Needleman F (1982) Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic rabbit kidney. Circ Res 50: 486–490

    PubMed  CAS  Google Scholar 

  29. Roscher R, Oettinger W, Beger HG (1985) Freisetzung endogener Prostaglandine beim mechanischen Dünndarmileus. In: Chirurgisches Forum. Springer, Berlin Heidelberg New York Tokyo, pp 275–278

    Google Scholar 

  30. Seeling W, Heinrich H, Oettinger W (1986) Das Eventerationssyndrom: Prostacyclinfreisetzung and akuter paO2-Abfall durch Dünndarmeventeration. Anaesthesist 35: 738–743

    PubMed  CAS  Google Scholar 

  31. Toda N, Konishi M, Miyazaki M (1982) Involvement of endogenous prostaglandin I2 in the vascular action of histamine in dogs. J Pharmacol Exp Ther 223: 257–260

    PubMed  CAS  Google Scholar 

  32. Gryglewski RJ, Korbut RL, Ocetkiewicz AC (1978) Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature 272: 765–769

    Article  Google Scholar 

  33. Wennmalm A (1978) Prostaglandin-mediated inhibition of noradrenaline release. III. separation of PG release from stimulated hearts and analysis of the neurosecretion inhibitory capacity. Prostaglandins 15: 113–119

    Article  PubMed  CAS  Google Scholar 

  34. Ramwell P. Personal communication

    Google Scholar 

  35. Hechtman HB, Huval WV, Mathieson MA, Stemp LI, Valeri CR, Shepro D (1983) Prostaglandin and thromboxane mediation of cardiopulmonary failure. Surg Clin North Am 63: 263–288

    PubMed  CAS  Google Scholar 

  36. Wichtermann K, Baue A, Chaudry I (1980) Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res 29: 189–196

    Article  Google Scholar 

  37. Demling RH, Smith M, Gunther R, Flynn JT, Gee MH (1981) Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am Physiol Soc 348–353

    Google Scholar 

  38. Coker SJ, Hughes B, Parratt JR, Rodger IW, Zeitlin IJ (1983) The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmac 78: 561–570

    CAS  Google Scholar 

  39. Hüttemeier PC, Watkins WD, Peterson MB, Zapol WM (1982) Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep. Circ Res 50: 688–694

    PubMed  Google Scholar 

  40. Fink MP, Gardiner WM, Roethel R, Fletcher JR (1985) Plasma levels of 6-keto-PGFIn but not TXB2 increase in rats with peritonitis due to cecal ligation. Circ Shock 16: 297–305

    PubMed  CAS  Google Scholar 

  41. Hales CA, Sonne L, Peterson M, Kong D, Miller M, Watkins D (1980) Role of thromboxane and prostacyclin in pulmonary vasomotor changes. J Clin Invest 68: 497–503

    Article  Google Scholar 

  42. Webb PJ, Westwick J, Scully MF, Zahavi J, Kakkar V (1981) Do prostacyclin and thromboxane play a role in endotoxic shock? Br J Surg 68: 720–724

    Article  PubMed  CAS  Google Scholar 

  43. Kurtz JH, Quast J (1982) Effects of continuous intravenous infusion of Escherichia coli endotoxin infusion into swine. Am J Vet Res 43: 262–267

    PubMed  CAS  Google Scholar 

  44. Oettinger W, Peskar BA, Beger HG (1987) Profiles of endogenous prostaglandin F2„ thromboxane A2 and prostacyclin with regard to cardiovascular and organ functions in early septic shock in man. Eur Surg Res 19: 65–77

    Article  PubMed  CAS  Google Scholar 

  45. Peterson MB, Huttemeier PC, Zapol WM, Martin EG, Watkins WD (1982) Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion. Am Physiol Soc 471–479

    Google Scholar 

  46. Raflo GT, Wangensteen SL, Glenn TM, Lefer AM (1973) Mechanism of the protective effects of PGE2 and PGF2, in canine endotoxin shock. Eur J Pharmacol 24: 86–91

    Article  PubMed  CAS  Google Scholar 

  47. Oettinger W, Maunder RJ, Sager MA, Bach A (1984) The prostaglandin (PG)-system and non-septic pulmonary complications after multiple trauma: Exclusive release of thromboxane (TX) during the initial 36 hours. Eur Surg Res 16: 37

    Article  Google Scholar 

  48. Hirsh PD, Hillis LD, Campbell WD, Firth BG, Willerson JT (1981) Release of prostaglandin and thromboxanes into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–671

    Article  PubMed  CAS  Google Scholar 

  49. McCarthy J, Torres V, Romero J, Wochos D, Velosa J (1982) Acute intrinsic renal failure induced by indomethacin. Mayo Clin Proc 57: 289–294

    PubMed  CAS  Google Scholar 

  50. Lefer AM, Tabas J, Smith III EF (1980) Salutary effects of prostacyclin in endotoxin shock. Pharmacology 21: 206–211

    Article  PubMed  CAS  Google Scholar 

  51. Steinberg SM, Dehring DJ, Gower WR, Vento JM, Lowery BD, Cloutier CT (1982) Prostacyclin in experimental septic acute respiratory failure. J Surg Res 34: 298–302

    Article  Google Scholar 

  52. Reines HD, Halushka PV, Olanoff LS, Hunt PS (1985) Dazoxiben in human sepsis and adult respiratory distress syndrome. Clin Pharmacol Ther 37: 390–395

    Google Scholar 

  53. Holcroft JW, Vassar MJ, Weber CJ (1986) Prostaglandin E, and survival in patients with the adult respiratory distress syndrome. A prospective trial. Ann Surg 203: 371–378

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Oettinger, W. (1987). Role of Prostaglandins and Thromboxane. In: Vincent, J.L., Thijs, L.G. (eds) Septic Shock. Update in Intensive Care and Emergency Medicine, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83108-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83108-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17861-3

  • Online ISBN: 978-3-642-83108-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics